Mumbai, February 27, 2018: Pharma real Walks Shasun said it has chosen to dispatch the ‘over the counter’ form of ulcer medicate Ranitidine in 150 mg measurement in the US advertises quickly.
Steps Shasun is now a key player in the US Ranitidine showcase with 32 percent piece of the overall industry through its remedy form in 150 mg and 300 mg measurements.
The new dispatch will additionally fortify organization’s Ranitidine establishment.
As indicated by IRI information, the US OTC market for Ranitidine Tablets, which is the non specific type of the prominent brand Zantac, is around USD 200 million.
This is likewise the principal item endorsement from organization’s 50:50 JV with Vivimed Labs.
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…
Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…